UPDATED PRESENTATION TIME FOR MAY 22: Medidata to Present at Upcoming Investor Conference
May 15 2017 - 5:30PM
Business Wire
Medidata (NASDAQ:MDSO), the leading global provider of
cloud-based technology and data analytics for clinical research,
today announced that the company will present at the following
upcoming investor conferences.
- Rouven Bergmann, chief financial
officer, will present at the Needham Emerging Technology Conference
on Tuesday, May 16, 2017, at 8:00 a.m. ET in New York.
- Tarek Sherif, chief executive officer,
will present at the J.P. Morgan 45th Annual Global Technology,
Media and Telecom Conference on Monday, May 22, 2017, at 10:00 a.m.
ET in Boston.
A live audio webcast will be available on the “Investor” section
of Medidata’s website at http://investor.mdsol.com. Please visit
the website at least 15 minutes prior to the event to register,
download and install any necessary audio or video software to
access the presentation. For those unable to participate in the
live webcast, a replay will be archived on the “Investor” section
of Medidata’s website at http://investor.mdsol.com for a limited
period of time following the conference.
About Medidata
Medidata is reinventing global drug and medical device
development by creating the industry's leading cloud-based
solutions for clinical research. Through our advanced applications
and intelligent data analytics, Medidata helps advance the
scientific goals of life sciences customers worldwide, including
over 850 global pharmaceutical companies, biotech, diagnostic and
device firms, leading academic medical centers, and contract
research organizations.
The Medidata Clinical Cloud® brings a new level of quality and
efficiency to clinical trials that empower our customers to make
more informed decisions earlier and faster. Our unparalleled
clinical trial data assets provide deep insights that pave the way
for future growth. The Medidata Clinical Cloud is the primary
technology solution powering clinical trials for 18 of the world's
top 25 global pharmaceutical companies and is used by 18 of the top
25 medical device developers—from study design and planning through
execution, management and reporting.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170515006687/en/
Medidata SolutionsInvestors:Anthony
D’Amico, +1 732-767-4331adamico@mdsol.comorMedia:Erik
Snider, +1 646-362-2997esnider@mdsol.com
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Apr 2023 to Apr 2024